Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential
Has Nominated Seven Highly Qualified Independent Directors
Believes AREX Slate Would Provide Board With
“We are disappointed that Enhabit’s strategic review process has concluded without a sale of the Company. We do not believe that this failure reflects Enhabit’s intrinsic value or strategic potential. Rather, this failure lies with Enhabit’s Board. In March, we nominated a slate of seven highly qualified candidates to stand for election at the 2024 Annual Meeting. We chose not to publicly disclose our nomination to avoid disrupting the strategic review process to the detriment of shareholders, but clearly our hope that this Board might finally deliver a positive result for its shareholders was wishful thinking.
We believe that Enhabit’s lackluster operating performance relative to peers over the past two years plainly demonstrates that the Board urgently needs the deep operational expertise in home health and hospice that the AREX Slate would bring. The AREX Slate is eager to begin the work of driving improvement at
AREX SLATE BIOGRAPHIES
Chief People Officer ofIvy Rehab Network, Inc. , an industry-leading outpatient and pediatric healthcare provider offering physical, occupational, speech and ABA therapy.- Previously served as the Senior Vice President of Workforce Strategy, HR Innovation & Total Rewards at Amedisys, Inc. (“Amedisys”), a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place, from 2018 to 2022, as well as the Interim Chief Human Resources Officer of Amedisys from
March 2022 toOctober 2022 .
- Partner at
AREX Capital Management . - Previously a member of the board directors of Tuesday Morning Corporation (NASDAQ: TUES), an off-price retailer, from 2017 to 2020, where he served on the Audit and Nominating and Governance Committees.
- Chief Executive Officer of
HealthPRO Heritage , a national rehabilitation and health innovations company. - Previously served as President of the
Home and Community Based Services Division of LHC Group, Inc., a provider of in-home healthcare services and innovations for communities around the nation, from 2019 to 2023. - Previously served as Chief Operating Officer of
Addus HomeCare Corporation (NASDAQ: ADUS), a leading provider home care services that include personal care services that assist with activities of daily living, from 2014 to 2017. - Previously served as Senior Vice President of Enterprise Operations of Amedisys from 2012 to 2014, and
AllianceCare, Inc. , a private equity owned home healthcare company, from 2008 to 2012.
- Most recently served as the Managing Member of
Four Peaks Advisors, LLC , a consulting practice focused on post-acute healthcare and related businesses, from 2016 to 2023. - Previously served as President for
Brookdale Senior Living, Inc. (“Brookdale”) (NYSE: BKD), the largest operator of senior living communities inthe United States . During his tenure at Brookdale, he served in a variety of executive leadership roles for Brookdale and one of its predecessor companies from 1997 to 2016, including service as Brookdale’s Chief Financial Officer from 2006 to 2015. - Previously served as Vice President and CFO for
VITAS Healthcare Corporation , the nation’s largest hospice and palliative care provider, from 1990 to 1997.
Anna-Gene O’Neal
Ms. O’Neal brings 35 years of healthcare experience, including leadership positions in home health and hospice operations, and a demonstrated ability to grow revenue and improve the quality of patient care.
- Senior Vice President of
Home Health , Hospice, and Palliative Care at HarmonyCares, aMichigan -based provider of comprehensive home-based healthcare services. - Previously served as the President of Brookdale’s Health Care Services division, where she was responsible for home health, hospice, and outpatient therapy, from 2019 to 2021. She subsequently served as President, Hospice Service Line for
HCA Healthcare, Inc. (NYSE: HCA) (“HCA”) from 2021 to 2022, following HCA’s acquisition of a majority stake in the business. - Previously served as President and CEO of
Alive Hospice , aTennessee -based non-profit hospice provider consistently ranked among the best in the nation, from 2012 to 2019.
Dr.
- Previously served as Interim President, Home Solutions at
Humana, Inc. (NYSE: HUM) from 2021 to 2022, as well as Chief Medical Officer, Home Solutions, from 2020 to 2022. He oversaw Humana’s home-focused delivery segment, where he was responsible for operations, partnerships, and integration of multiple home-based care assets, from primary care to hospital at home to Medicare-certified home health. - Previously served as Executive Vice President and Chief Medical Officer of
AccentCare , one of the nation’s leaders in home-based healthcare services, from 2015 to 2019.
- President and Chief Executive Officer of
MyLaurel Health , a leader in providing high-acuity, high-complexity care in patients’ homes. - Previously served as Chief Executive Officer of myNEXUS, a leading provider of comprehensive home-based nursing management to health insurers, from 2019 until its successful sale in 2021 to
Anthem Inc. (now known asElevance Health, Inc. (NYSE: ELV)). He also served myNEXUS as a Vice Chairman and in a strategic advisor role from 2018 to 2019. - Previously spent over two decades with HCA and its predecessor companies from 1993 to 2016. Most recently he served as Senior Vice President of Employer and Payer Engagement with responsibility for over
$30 billion in net revenue.
About AREX
Media Contact
(646) 679-4000
info@arexcapital.com
CERTAIN INFORMATION CONCERNING THE PARTICIPANTS
AREX CAPITAL MASTER STRONGLY ADVISES ALL STOCKHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE
The participants in the proxy solicitation are anticipated to be AREX Capital Master,
As of the date hereof, AREX Capital Master directly beneficially owns 549,277 shares of common stock, par value
Source:
2024 GlobeNewswire, Inc., source